An industry funded study concludes the branded palmitoylethanolamide (PEA) ingredient ‘Levagen+’ is safe and effective in reducing the incidence and symptoms associated with upper respiratory tract infections (URTIs).
Gencor’s Levagen, a clinically studied form of palmitolethanolamide (PEA), has been granted novel foods certification by Brazil’s National Health Surveillance Agency ANVISA.